The objective of the investigation is to formulate self-nanoemulsifying drug delivery system (SNEDDS) of Vitamin A (tocopherol) to improve its aqueous solubility as its fat-soluble vitamin. Settings, Design, Methodology: Solubility of Vitamin A in various oil surfactants and cosurfactants is determined. Ternary phase diagram is constructed at different ratios of surfactant and co-surfactants to determine self-emulsifying region. Effect of oil content, pH of aqueous phase and mean globule size of resulting nanoemulsion is studied. Optimized formulation was identified and was evaluated for in vitro dissolution profile in comparison with pure drug. Results: Self-emulsifying drug delivery systems yielded nanoemulsion with globule size range of 81.7 nm with the Z average of 504.4 nm indicating all the particles were in nano-meter range. Drug content was measured and found to be 99.62% in optimized formulation A20. Phase inversion is not noticed after thermodynamic studies. Conclusion: SNEDDS of Vitamin A comprising of clove oil, Tween 40, and polyethylene glycol 600 were prepared for enhancing the dissolution and bioavailability. SNEDDS were optimized based on the optimum globule size, increased dissolution, and drug release. Close to complete drug release was achieved from the formulation A20 which is significantly higher as compared to that of other formulations.
INTRODUCTION
A pproximately 40% of new drug candidates have poor water solubility, and the oral delivery of such drugs is frequently associated with low bioavailability, high intra-and intersubject variability, and a lack of dose proportionality. [1] To overcome these problems, various formulation strategies are exploited. Recently, much attention has been paid to lipid-based formulations with particular emphasis on self-emulsifying drug delivery systems (SEDDS) to improve the oral bioavailability of lipophilic drugs. [2, 3] SEDDS are defined as isotropic mixtures of natural or synthetic oils, solid or liquid surfactants or alternatively, one or more hydrophilic solvents, and cosolvents/surfactants. [4] On mild agitation followed by dilution in aqueous media, such as gastrointestinal (GI) fluids, these systems can form fine oil-in-water (o/w) emulsions or microemulsions (self-microemulsifying drug delivery systems [SMEDDS]). Fine oil droplets would pass rapidly from the stomach and promote wide distribution of the drug throughout the GI tract, thereby minimizing the irritation frequently encountered during extended contact between bulk drug substances and the gut wall. When compared with emulsions, which are sensitive and metastable dispersed forms, SMEDDS are physically stable formulations that are easy to manufacture. An additional advantage of SMEDDS over simple oily solutions is that they provide a large interfacial area for partitioning of the drug between oil and water. [5, 6] 
METHODOLOGY

Solubility studies
Solubility of Vitamin A in various oils was determined using shake-flask method of determining solubility; in this method, excess of drug was added to vials containing 1 ml of excipients and was vortexed for 10 min and then shaken for 48 h at 25°C, and visual inspection is done after 48 h. [7] 
Emulsification studies
From the large pool of surfactants, surfactant with best self-emulsifying abilities was selected. The selected oil and surfactant were mixed in 1:3 ratio and heated up to 40-45°C and then vortexed to form homogeneous mixture. The ratio of oil to surfactant was decided on the basis of requirement by Pouton. Various cosurfactants were screened by mixing surfactants with cosurfactants in 2:1 ratio; oily phase was added to this mixture in 1:3 ratio, and then, they were heated and vortexed gently to form a homogeneous mixture and were evaluated visually. [8] 
Construction of pseudoternary phase diagram
Pseudoternary phase diagram of oil, surfactant, cosurfactant, and water was developed using titration method at 25 ± 2°C; phase behavior system was studied at 1:1, 2:1, 3:1, and 4:1 ratios of surfactant and cosurfactant, and the resulting mixture was evaluated visually for transparency. The endpoint of titration where mixture becomes turbid or phase separation was observed at this point; amount of water surfactant and cosurfactant used is noted. [7] 
Preparation of Vitamin A self-nanoemulsifying drug delivery system (SNEDDS)
Vitamin A self-emulsifying system was prepared by dissolving drug in cosurfactant in a transparent glass vial; then, calculated quantities of surfactant and oil were transferred into the above vial, and components in vial were mixed thoroughly and heated at 40-50°C to form homogeneous mixture and were stored at room temperature until used.
Globule size analysis
The mean globule size was analyzed using Zetasizer with the following parameters: [9] Stability studies Thermodynamic stability studies of optimized formulation of Vitamin A SNEDDS were assessed as per the ICH guidelines.
RESULTS AND DISCUSSION
Solubility studies
Preliminary solubility analysis was carried out to select the appropriate excipient from various oils such as clove oil, cotton seed oil, olive oil, castor oil, eucalyptus oil, emu oil, sesame oil, and oleic acid; surfactants such as Tween 40, Tween 80, Span 60, and Span 80; and cosurfactants such as polyethylene glycol (PEG) 600. Based on drug solubility, clove oil was used as oil phase and Tween 40 and PEG 600 were used as surfactant and cosurfactant, respectively 
Pseudoternary phase diagram
From the solubility studies, clove oil, Tween 40 and PEG 600 were selected as oil, surfactant and co-surfactant respectively. From the phase diagram [ Figure 4 ] it was observed that self-emulsifying region was enhanced with increasing concentrations of surfactant and cosurfactant with oil. The efficiency of self-emulsification was good when the surfactant concentration increased. [10, 11] 
Visual observation
With the use of visual observation method, the tendency of formation of emulsion was observed. Visual observation test was performed for different ratios by keeping the surfactant and cosurfactant ratio (Smix) as 1:1, 2:1, 3:1, and 4:1. Grades were given to the ratios based on the tendency of formation of microemulsion. The ratios 1:9, 2:8, 3:7, and 4:6 of Smix 1:1 and 1:9, 2:8, 3:7, 4:6, and 5:5 of Smix 2:1 and 1:9, 2:8, 3:7, 4:6, 5:5, and 6:4 of Smix 3:1 and 1:9, 2:8, 3:7, 4:6, 5:5, and 6:4 of Smix 4:1 showed rapid formation of microemulsion within a minute having a clear appearance. Therefore, these ratios were selected for the formulation of SNEDDS [ Table 1 and Figures 5 and 6 ].
Thermodynamic stability studies
No phase separation and effect of temperature variations on prepared formulations were observed during thermodynamic stability studies. There was no change in the visual description of samples after centrifugation freeze-thaw cycles. Formulations which are thermodynamically stable only were selected for further characterization.
% Transmittance (%T) measurement
The clarity of microemulsion was checked by transparency, measured in terms of %T. SNEDDS forms o/w microemulsion since water is external phase formulation (A20), which has %T value >99%. These results indicate the high clarity of microemulsion. In case of other systems, %T values were <99%, suggesting less clarity of microemulsion. This may be due to a greater particle size of the formulation. Due to higher particle size, oil globules may reduce the transparency of microemulsion and thereby values of %T [ Table 2 ].
Drug content of SMNDDS
Maximum % drug content was found to be 99.62% which was found in the formulation A20 [ Table 2 ].
In-vitro dissolution studies of SNEDDS
The faster dissolution from SNEDDS may be attributed to the fact that in this formulation, the drug is a solubilized form and on exposure to dissolution medium results in small droplet that can dissolve rapidly in the dissolution medium. The release from liquid SNEDDS formulation (A20) was faster and higher than other SNEDDS formulations indicating influence of droplet size on the rate of drug dissolution [ Figures 6-9 ].
Particle size analysis of SNEDDS
Droplet size determines the rate and extent of drug release as well as drug absorption. Smaller the particle size, larger the interfacial surface area which may lead to more rapid absorption and improved bioavailability. SNEDDS with a mean droplet size below 200 nm exhibit excellent bioavailability. The particle size of the emulsion is a crucial factor in selfemulsification performance because it determines the rate and extent of drug release as well as absorption. The particle size of the optimized SNEDDS formulation (A20) was found to be 81.7 nm and Z-average of 504.4 nm, indicating all the particles were in the nanometer range [ Figure 10 ].
Zeta potential of SNEDDS
Zeta potential is responsible for the degree of repulsion between adjacent, similarly charged, dispersed droplets. A zeta potential value of ±30 mV is sufficient for the stability of a microemulsion. The zeta potential of the optimized SNEDDS formulation (A20) was found to be −16.7 mV which complies with the requirement of the zeta potential for stability [ Figure 11 ]. [12, 13] CONCLUSION SNEDDS of Vitamin A comprising of clove oil, Tween 40, and PEG 600 were prepared for enhancing the dissolution and bioavailability. SNEDDS were optimized based on the optimum globule size, increased dissolution, and drug release. Close to complete drug release was achieved from the formulation A20 which is significantly higher as compared to that of other formulations. 
